$SLDC
Telco Cuba, Inc. Stock $sldc

$sldc Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000109991023000020 Filed on January 23, 2023

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$31.68K	$38.15K
YoY Change	-16.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$97.97K	$177.6K
YoY Change	-44.85%
Operating Profit	-$66.29K	-$139.5K
YoY Change	-52.48%
Interest Expense	$52.98K	$301.8K
YoY Change	-82.44%	-205.54%
% of Operating Profit
Other Income/Expense, Net	-$97.86K	$634.2K
YoY Change	-115.43%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$164.2K	$494.7K
YoY Change	-133.19%	-273.0%
Net Earnings / Revenue	-518.19%	1296.64%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	223.4M shares	125.4M shares
Diluted Shares Outstanding	1.201B shares	954.7M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$9.362K	$7.592K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$5.450K
Prepaid Expenses
Receivables	$3.609K
Other Receivables
Total Short-Term Assets	$19.92K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$11.75K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$11.75K
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$19.92K
Total Long-Term Assets	$11.75K
Total Assets	$31.67K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$201.3K
YoY Change
Accrued Expenses	$2.265M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.491M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.491M
Total Long-Term Liabilities
Total Liabilities	$5.491M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$6.278M
YoY Change
Common Stock	$235.1K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.459M	-$5.666M
YoY Change
Total Liabilities & Shareholders Equity	$31.67K
YoY Change

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$164.2K	$494.7K
YoY Change	-133.19%	-273.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$99.62K	-$80.12K
YoY Change	-224.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid		$62.14K
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$111.7K	$75.98K
YoY Change	-246.98%
NET CHANGE
Cash From Operating Activities	$99.62K	-$80.12K
Cash From Investing Activities
Cash From Financing Activities	-$111.7K	$75.98K
Net Change In Cash	-$12.05K	-$4.135K
YoY Change	191.46%
FREE CASH FLOW
Cash From Operating Activities	$99.62K	-$80.12K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-02-28
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2017Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2017Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2017Q1	dei	Entity File Number EntityFileNumber	000-53157
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	TELCO CUBA, INC.
CY2017Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001427644
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2016Q4	us-gaap	Deposits Assets DepositsAssets		usd
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2016Q1	QBAN	Conversion Of Preferred B To Common Shares ConversionOfPreferredBToCommonShares		usd
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2016Q1	QBAN	Depreciations Depreciations		usd
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2017Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2017Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2017Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2016Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2017Q1	QBAN	Preferred B Stock Conversion To Common Shares PreferredBStockConversionToCommonShares		usd
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2017Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2017Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0546544
CY2017Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	454 S Yonge Street
CY2017Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 3A
CY2017Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ormond Beach
CY2017Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2017Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32174
CY2017Q1	dei	City Area Code CityAreaCode	305
CY2017Q1	dei	Local Phone Number LocalPhoneNumber	747-7647
CY2017Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2017Q1	dei	Entity Shell Company EntityShellCompany	false
CY2017Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2017Q1	dei	Trading Symbol TradingSymbol	QBAN
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	235141501	shares
CY2017Q1	us-gaap	Cash Cash	9362	usd
CY2016Q4	us-gaap	Cash Cash	21414	usd
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3609	usd
CY2017Q1	us-gaap	Deposits Assets DepositsAssets	1500	usd
CY2017Q1	us-gaap	Inventory Net InventoryNet	5450	usd
CY2016Q4	us-gaap	Inventory Net InventoryNet	5450	usd
CY2017Q1	us-gaap	Assets Current AssetsCurrent	19921	usd
CY2016Q4	us-gaap	Assets Current AssetsCurrent	26864	usd
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6949	usd
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6686	usd
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11750	usd
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14738	usd
CY2017Q1	us-gaap	Assets Assets	31671	usd
CY2016Q4	us-gaap	Assets Assets	41602	usd
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	201283	usd
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	167854	usd
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2264918	usd
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2088082	usd
CY2017Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	135221	usd
CY2016Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	120577	usd
CY2017Q1	QBAN	Convertible Debentures Related Parties ConvertibleDebenturesRelatedParties	15000	usd
CY2016Q4	QBAN	Convertible Debentures Related Parties ConvertibleDebenturesRelatedParties	15000	usd
CY2017Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2156626	usd
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2236446	usd
CY2017Q1	QBAN	Convertible Debenture ConvertibleDebenture	540344	usd
CY2016Q4	QBAN	Convertible Debenture ConvertibleDebenture	621843	usd
CY2017Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177390	usd
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	132098	usd
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5490782	usd
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5381900	usd
CY2017Q1	us-gaap	Liabilities Liabilities	5490782	usd
CY2016Q4	us-gaap	Liabilities Liabilities	5381900	usd
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	235141501	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	235141501	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	214631331	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	214631331	shares
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	235141	usd
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	214631	usd
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	583760	usd
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	558926	usd
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6278350	usd
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6114193	usd
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-5459111	usd
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-5340298	usd
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31671	usd
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41602	usd
CY2017Q1	us-gaap	Revenues Revenues	31679	usd
CY2016Q1	us-gaap	Revenues Revenues	38149	usd
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	97972	usd
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	177645	usd
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-66293	usd
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-139496	usd
CY2017Q1	us-gaap	Interest Expense InterestExpense	52975	usd
CY2016Q1	us-gaap	Interest Expense InterestExpense	301758	usd
CY2017Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-44889	usd
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	721873	usd
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	214036	usd
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-97864	usd
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	634151	usd
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-164157	usd
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	494655	usd
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0007
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0039
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0007
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0005
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223366678	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125412657	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1200845875	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	954725174	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-6167953	usd
CY2016Q1	QBAN	Note Payable Conversion NotePayableConversion	7353	usd
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	494655	usd
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-5665945	usd
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-5340298	usd
CY2017Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	10344	usd
CY2017Q1	QBAN	Note Payable Conversion NotePayableConversion	35000	usd
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-164157	usd
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-5459111	usd
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-164157	usd
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	494655	usd
CY2017Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	44889	usd
CY2016Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-721873	usd
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10344	usd
CY2017Q1	QBAN	Depreciations Depreciations	2989	usd
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5109	usd
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	953	usd
CY2016Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3453	usd
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210667	usd
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	144603	usd
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	99623	usd
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80115	usd
CY2016Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	287267	usd
CY2017Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	111675	usd
CY2016Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	149150	usd
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	62137	usd
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-111675	usd
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75980	usd
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12052	usd
CY2016Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4135	usd
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21414	usd
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11727	usd
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9362	usd
CY2016Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7592	usd
CY2016Q1	QBAN	Preferred B Stock Conversion To Common Shares PreferredBStockConversionToCommonShares	1200	usd
CY2017Q1	us-gaap	Stock Issued1 StockIssued1	2000	usd
CY2016Q1	us-gaap	Stock Issued1 StockIssued1	7353	usd
CY2017Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_z1WPPwKzT4p6" style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82A_zk17noHYgSW7">Nature of Operations and Going Concern</span></b></span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telco Cuba, Inc. (fka CaerVision Global, Inc., fka American Mineral Group Minerals Inc.) (the "Company") was incorporated in the State of Nevada on August 10, 2007. Up until June 12, 2015, the company was previously engaged in the exploration, development, and acquisition of mineral properties.</span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 12, 2015, the Company consummated a Share Exchange with Amgentech, Inc., a Florida corporation. <span id="xdx_907_ecustom--SharesExchangeDescription_c20161201__20170228" title="Shares Exchange description">Under the terms of the Share Exchange, the holders of Amgentech received 50,088 shares of Series B Preferred Stock that had been previously issued to third parties in exchange for 100% of the issued and outstanding capital of Amgentech. Each share of Series B preferred is convertible into 5,000 shares of common stock (254,440,000 shares total) and has voting rights of 5,000 per share (254,440,000 votes).</span> As a result of this transaction, Amgentech became a wholly owned subsidiary of the Company with control transferring to the previous owners of Amgentech. Amgentech elected to be treated as the successor issuer for SEC reporting and accounting purposes. The Share Exchange was accounted for as a reverse acquisition and re-capitalization. The Amgentech Shareholders obtained approximately 60% of voting control on the date of Share Exchange. Amgentech was the acquirer for financial reporting purposes and the Company was the acquired company. <span style="line-height: 107%"> </span>The Company filed an amendment to its articles of incorporation and changed its name to Telco Cuba, Inc. Telco Cuba is foremost a technology solutions service provider offering services under the brand names “Amgentech” and “Telco Cuba”.</span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on the basis of accounting principles applicable to a going concern; accordingly, they do not give effect to adjustments that would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and retire its liabilities in other than the normal course of business and at amounts different from those in the accompanying financial statements. As shown in the accompanying financial statements, the Company has an accumulated deficit of $<span id="xdx_90E_eus-gaap--RetainedEarningsAppropriated_iI_pdn3_dm_c20170228_z4K2jEeqMJL4" title="Accumulated deficit">4.962</span> million. <span style="background-color: white">The Company currently does not have the cash resources to meet its operating commitments for the next twelve months and expects to have ongoing requirements for capital investment or debt to implement its business plan. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern for a reasonable period of time.</span> Management plans to raise cash from public or private debt or equity financing, on an as needed basis. The Company's ability to continue as a going concern is in substantial doubt unless it can achieve profitable operations and/or upon obtaining additional financing. The outcome of these matters cannot be predicted at this time.</span></p>
CY2017Q1	QBAN	Shares Exchange Description SharesExchangeDescription	Under the terms of the Share Exchange, the holders of Amgentech received 50,088 shares of Series B Preferred Stock that had been previously issued to third parties in exchange for 100% of the issued and outstanding capital of Amgentech. Each share of Series B preferred is convertible into 5,000 shares of common stock (254,440,000 shares total) and has voting rights of 5,000 per share (254,440,000 votes).
CY2017Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	4962000	usd
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	132098	usd
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223366678	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125412657	shares
CY2017Q1	QBAN	Convertible Debentures ConvertibleDebentures	499204197	shares
CY2016Q1	QBAN	Convertible Debentures ConvertibleDebentures	473782517	shares
CY2017Q1	QBAN	Convertible Preferred Stock ConvertiblePreferredStock	478275000	shares
CY2016Q1	QBAN	Convertible Preferred Stock ConvertiblePreferredStock	355530000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1200845875	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	954725174	shares
CY2017Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177390	usd
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zZJZDvg5zlAe" style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>g) <span id="xdx_863_z5K2uXoxtXTd">Estimates</span></b></span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with US generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from those reported.</span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"/></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b/></span></p>
CY2017Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zJlOG4ACoFU2" style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>h) <span id="xdx_868_z8yc5EqXMBTl">Accounts receivable and concentration of credit risk</span></b></span></p> <p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company provides credit to its clients in the form of payment terms. The Company limits its credit risk by performing credit evaluations of its clients and maintaining a reserve, if deemed necessary, for potential credit losses. Such evaluations include the review of a customer’s outstanding balances with consideration towards such customer’s historical collection experience, as well as prevailing economic and market conditions and other factors. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company currently has no accounts receivable in 2016 and, therefore, does not currently have a concentrated credit risk associated with trade receivables.</span></p>
CY2016Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2015Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	400000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	400000	shares
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	10000000	shares
CY2016Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	35000	usd
CY2016Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0035
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	400000	shares
CY2017Q1	QBAN	Preferred Stock Designated PreferredStockDesignated	300000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2017Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2016Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2017Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-57400	usd
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	173100	usd
CY2017Q1	QBAN	Utilization Increase In Tax Loss Carryforward UtilizationIncreaseInTaxLossCarryforward	-57400	usd
CY2016	QBAN	Utilization Increase In Tax Loss Carryforward UtilizationIncreaseInTaxLossCarryforward	173100	usd
CY2017Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6500000	usd
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	540344	usd
CY2016Q4	us-gaap	Convertible Debt ConvertibleDebt	621843	usd
CY2017Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	499204917	shares
CY2016Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	473782517	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.5294	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.5294	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y3M
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y3M
CY2017Q1	us-gaap	Share Price SharePrice	0.004
CY2016Q4	us-gaap	Share Price SharePrice	0.004
CY2017Q1	us-gaap	Notes Payable NotesPayable	2156626	usd
CY2016Q1	us-gaap	Notes Payable NotesPayable	2236446	usd
CY2017Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	46110	usd
CY2016Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	47740	usd
CY2017Q1	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	135221	usd
CY2016Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	135577	usd
CY2017Q1	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.12	pure

Files In Submission

Name	View Source	Status
0001099910-23-000020-index-headers.html	Edgar Link	pending
0001099910-23-000020-index.html	Edgar Link	pending
0001099910-23-000020.txt	Edgar Link	pending
0001099910-23-000020-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qban-20170228.xsd	Edgar Link	pending
qban10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qban-20170228_cal.xml	Edgar Link	unprocessable
qban-20170228_def.xml	Edgar Link	unprocessable
qban-20170228_lab.xml	Edgar Link	unprocessable
qban-20170228_pre.xml	Edgar Link	unprocessable
qban10q_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLDC
Telco Cuba, Inc. Stock $sldc

2017 Q1 Form 10-Q Financial Statement

#000109991023000020 Filed on January 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLDC Telco Cuba, Inc. Stock $sldc

2017 Q1 Form 10-Q Financial Statement

#000109991023000020 Filed on January 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLDC
Telco Cuba, Inc. Stock $sldc